Factors Affecting Platelet-Rich Plasma Success in Patients With Diabetic Foot Ulcer
- PMID: 37485222
- PMCID: PMC10362885
- DOI: 10.7759/cureus.40803
Factors Affecting Platelet-Rich Plasma Success in Patients With Diabetic Foot Ulcer
Abstract
Introduction Diabetic foot ulcers (DFU) are one of the most common complications of diabetes mellitus (DM). The use of platelet-rich plasma (PRP) in the treatment of DFU has been increasing in recent years. In the current study, we aimed to evaluate the factors affecting the success of PRP in the management of DFU. Methods The present study was planned in a prospective manner, and we enrolled patients with DFU in the study. Patients' characteristics, DFU properties, and treatment outcomes were recorded. Patients with DFU were classified into two groups according to PRP success: healed DFU patients in Group 1 and non-healed DFU patients in Group 2. Groups were compared according to patient characteristics and treatment outcomes, and multivariate regression analysis was performed to clarify factors that predicted PRP success. Results In total, 182 patients were enrolled in the study, and DFU in 141 (77.5%) patients healed with PRP treatment. The mean body mass index (BMI) was significantly higher in the non-healed patients (p= 0.005). The smoking rate was 58.5% in the non-healed group and 39.7% in the healed group (p= 0.016). The duration of DM (17.9 years vs. 22.5 years, p= 0.003) was significantly longer, and patients with glomerular filtration rate (GFR) < 60 (44.0% vs. 63.4, p= 0.028) were significantly more common in the non-healed group. Multivariate regression analysis demonstrated that BMI ≥30 kg/m2 and duration of DM ≥20 years were predictive factors for PRP failure in patients with DFU (p= 0.019 and p= 0.005). Smoking and GFR <60 were significantly associated with PRP failure (p= 0.040 and p= 0.044). Conclusion In our study, it was found that PRP was an effective treatment that improved DFU in 141 out of 182 patients. Moreover, the present study demonstrated for the first time that higher BMI, longer duration of DM, smoking, and lower GFR were significantly related to PRP failure in patients with DFU.
Keywords: diabetes mellitus; diabetic foot ulcer; glomerular filtration rate; obesity; prp; smoking.
Copyright © 2023, Kanber et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
Similar articles
-
Platelet-Rich Plasma in Diabetic Foot Ulcer Healing: Contemplating the Facts.Int J Mol Sci. 2024 Nov 29;25(23):12864. doi: 10.3390/ijms252312864. Int J Mol Sci. 2024. PMID: 39684575 Free PMC article. Review.
-
Efficacy of Platelet-Rich Plasma in the Treatment of Diabetic Foot Ulcer.Cureus. 2024 May 23;16(5):e60934. doi: 10.7759/cureus.60934. eCollection 2024 May. Cureus. 2024. PMID: 38910752 Free PMC article.
-
A cohort study of diabetic patients and diabetic foot ulceration patients in China.Wound Repair Regen. 2015 Mar-Apr;23(2):222-30. doi: 10.1111/wrr.12263. Wound Repair Regen. 2015. PMID: 25682850
-
Risk factors for diabetic foot ulcers: an Albanian retrospective study of inpatients with type 2 diabetes.Eur Rev Med Pharmacol Sci. 2022 Jan;26(2):558-572. doi: 10.26355/eurrev_202201_27883. Eur Rev Med Pharmacol Sci. 2022. PMID: 35113432
-
Novel biological therapies for the treatment of diabetic foot ulcers.Expert Opin Biol Ther. 2017 Aug;17(8):979-987. doi: 10.1080/14712598.2017.1333596. Epub 2017 Jun 1. Expert Opin Biol Ther. 2017. PMID: 28532226 Review.
Cited by
-
Platelet-Rich Plasma Inhibits Breast Cancer Proliferation.Clin Med Insights Oncol. 2024 Nov 16;18:11795549241298978. doi: 10.1177/11795549241298978. eCollection 2024. Clin Med Insights Oncol. 2024. PMID: 39555114 Free PMC article.
-
[Ulcers and diabetic foot : Modern and alternative treatment strategies].Dermatologie (Heidelb). 2025 Jan;76(1):3-8. doi: 10.1007/s00105-024-05442-4. Epub 2024 Dec 17. Dermatologie (Heidelb). 2025. PMID: 39690198 Free PMC article. Review. German.
-
Platelet-Rich Plasma in Diabetic Foot Ulcer Healing: Contemplating the Facts.Int J Mol Sci. 2024 Nov 29;25(23):12864. doi: 10.3390/ijms252312864. Int J Mol Sci. 2024. PMID: 39684575 Free PMC article. Review.
-
Platelet concentrates in diabetic foot ulcers: A comparative review of PRP, PRF, and CGF with case insights.Regen Ther. 2025 Feb 21;28:625-632. doi: 10.1016/j.reth.2025.02.005. eCollection 2025 Mar. Regen Ther. 2025. PMID: 40166040 Free PMC article.
References
-
- Diabetes mellitus statistics on prevalence and mortality: facts and fallacies. Zimmet P, Alberti KG, Magliano DJ, Bennett PH. Nat Rev Endocrinol. 2016;12:616–622. - PubMed
-
- A cost-effectiveness analysis comparing single-use and traditional negative pressure wound therapy to treat chronic venous and diabetic foot ulcers. Kirsner RS, Delhougne G, Searle RJ. https://pubmed.ncbi.nlm.nih.gov/32294054/ Wound Manag Prev. 2020;66:30–36. - PubMed
-
- Cost-effectiveness of platelet-rich plasma for diabetic foot ulcer in Spain. Linertová R, Del Pino-Sedeño T, Pérez LG, et al. Int J Low Extrem Wounds. 2021;20:119–127. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials